Kodiak Sciences KOD
NASDAQ KOD
$87.63 +1.85 (+2.16%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kodiak Sciences (KOD) Sale and Maturity of Investments (2019 - 2023)

Updated

Analysis

Kodiak Sciences (KOD) Sale and Maturity of Investments (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Kodiak Sciences 5.51 Bn 4.93 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 105.00 Mn
Mar 31, 2023 235.00 Mn
Dec 31, 2022 72.00 Mn
Sep 30, 2022 66.00 Mn
Jun 30, 2021 8.50 Mn
Mar 31, 2021 16.00 Mn
Dec 31, 2020 64.00 Mn
Sep 30, 2020 58.00 Mn
Jun 30, 2020 56.85 Mn
Mar 31, 2020 19.30 Mn
Dec 31, 2019 -2.40 Mn
Sep 30, 2019 4.80 Mn
API Access

Kodiak Sciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=KOD&period=max&api_key=YOUR_API_KEY